Literature DB >> 19207293

Biomarkers of body iron stores and risk of developing type 2 diabetes.

S N Rajpathak1, J Wylie-Rosett, M J Gunter, A Negassa, G C Kabat, T E Rohan, J Crandall.   

Abstract

AIM: Iron may contribute to the pathogenesis of type 2 diabetes mellitus (DM) by inducing oxidative stress and interfering with insulin secretion. Elevated ferritin levels are associated with increased DM risk among healthy individuals. However, it is yet unknown if ferritin predicts DM incidence among high-risk individuals with impaired glucose tolerance (IGT). Furthermore, the association between soluble transferrin receptors (sTfR), a novel marker of iron status, and DM risk has not yet been prospectively investigated in these individuals. We conducted this study to evaluate the association between baseline levels of ferritin and sTfR and the risk of developing DM among overweight and obese individuals at high risk of DM.
METHODS: This nested case-control study (280 cases and 280 matched controls) was conducted within the placebo arm of the Diabetes Prevention Program, is a clinical trial conducted among overweight/obese individuals with IGT. Ferritin and sTfR levels were measured by immunoturbidimetric assays. Incident DM was ascertained by annual 75-g oral glucose tolerance test and semi-annual fasting glucose.
RESULTS: Compared with controls, cases had higher sTfR levels (3.50 +/- 0.07 vs. 3.30 +/- 0.06 mg/l; p = 0.03), but ferritin levels were not statistically different. The multivariable odds ratios (OR) and 95% confidence intervals (95% CI) for DM incidence comparing highest with the lowest quartiles of sTfR was 2.26 (1.37-4.01) (p-trend: 0.008).
CONCLUSIONS: Modestly elevated sTfR levels are associated with increased DM risk among overweight and obese individuals with IGT. Future studies should evaluate factors determining sTfR levels and examine if interventions that lower body iron stores reduce DM incidence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19207293      PMCID: PMC4758466          DOI: 10.1111/j.1463-1326.2008.00985.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  61 in total

1.  Relationship of cardiovascular risk factors and serum ferritin with C-reactive protein.

Authors:  Ki Chul Sung; Jin Ho Kang; Hun Sub Shin
Journal:  Arch Med Res       Date:  2007-01       Impact factor: 2.235

Review 2.  The transferrin receptor: role in health and disease.

Authors:  P Ponka; C N Lok
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

3.  Are body iron stores related to the risk of coronary heart disease?

Authors:  A Ascherio; W C Willett
Journal:  N Engl J Med       Date:  1994-04-21       Impact factor: 91.245

Review 4.  Iron and colorectal cancer risk: human studies.

Authors:  R L Nelson
Journal:  Nutr Rev       Date:  2001-05       Impact factor: 7.110

5.  Non-insulin-dependent diabetes mellitus and elevated serum ferritin level.

Authors:  T B Kaye; A T Guay; D C Simonson
Journal:  J Diabetes Complications       Date:  1993 Oct-Dec       Impact factor: 2.852

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  [Diabetes and hemochromatosis. II. Diabetes of idiopathic hemochromatosis and common diabetes. Apropos of 130 personal cases of hemochromatosis].

Authors:  M Simon; S Vongsavanthong; J P Jehan; M Roussey; M Bourel
Journal:  Sem Hop       Date:  1973-06-20

Review 8.  Microvascular complications of impaired glucose tolerance.

Authors:  J Robinson Singleton; A Gordon Smith; James W Russell; Eva L Feldman
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

9.  Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.

Authors:  Manuel Luque-Ramírez; Francisco Alvarez-Blasco; José I Botella-Carretero; Raul Sanchón; José L San Millán; Héctor F Escobar-Morreale
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

10.  Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study.

Authors:  N G Forouhi; A H Harding; M Allison; M S Sandhu; A Welch; R Luben; S Bingham; K T Khaw; N J Wareham
Journal:  Diabetologia       Date:  2007-03-02       Impact factor: 10.122

View more
  26 in total

1.  Association between serum ferritin levels and metabolic syndrome: an updated meta-analysis.

Authors:  Yuelong Jin; Lianping He; Yi Chen; Yun Fang; Yingshui Yao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.

Authors:  S Shalitin; V Deutsch; R Tauman
Journal:  J Endocrinol Invest       Date:  2018-01-05       Impact factor: 4.256

3.  Changes in iron measures over menopause and associations with insulin resistance.

Authors:  Catherine Kim; Bin Nan; Shengchun Kong; Siobhan Harlow
Journal:  J Womens Health (Larchmt)       Date:  2012-06-25       Impact factor: 2.681

4.  Dietary Nonheme, Heme, and Total Iron Intake and the Risk of Diabetes in Adults: Results From the China Health and Nutrition Survey.

Authors:  Jingjing He; Aiping Fang; Siwang Yu; Xin Shen; Keji Li
Journal:  Diabetes Care       Date:  2020-02-07       Impact factor: 19.112

5.  Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program.

Authors:  Jonathan Krakoff; Jeanne M Clark; Jill P Crandall; Charlton Wilson; Mark E Molitch; Frederick L Brancati; Sharon L Edelstein; William C Knowler
Journal:  Obesity (Silver Spring)       Date:  2010-02-25       Impact factor: 5.002

Review 6.  Pleiotropic actions of iron balance in diabetes mellitus.

Authors:  Xinhui Wang; Xuexian Fang; Fudi Wang
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

7.  The association of biomarkers of iron status with mortality in US adults.

Authors:  A Menke; P Muntner; J M Fernández-Real; E Guallar
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-02-16       Impact factor: 4.222

8.  Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study.

Authors:  Linéa Bonfils; Christina Ellervik; Nele Friedrich; Allan Linneberg; Camilla H Sandholt; Marit E Jørgensen; Torben Jørgensen; Torben Hansen; Oluf Pedersen; Kristine H Allin
Journal:  Diabetologia       Date:  2014-12-14       Impact factor: 10.122

9.  Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice.

Authors:  Jingyu Huang; Judith Simcox; T Creighton Mitchell; Deborah Jones; James Cox; Bai Luo; Robert C Cooksey; Laszlo G Boros; Donald A McClain
Journal:  FASEB J       Date:  2013-03-20       Impact factor: 5.191

10.  Trace element status in type 2 diabetes: A meta-analysis.

Authors:  Namrata Sanjeevi; Jeanne Freeland-Graves; S Natasha Beretvas; Prageet K Sachdev
Journal:  J Clin Diagn Res       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.